I don't want to be a killjoy or anything, but does anyone else feel like 17% growth over 12 months is a little soft given how amazing the product is?
Most companies would be well satisfied with these growth rates, but this is supposed to be early stage, big ramp up with high % growth company.
Tell me what I'm missing guys. When are the real big ticket sales supposed to be coming through?
avita medical reports strong half year financi, page-6
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.84 |
Change
-0.120(3.03%) |
Mkt cap ! $268.3M | |||
| Open | High | Low | Value | Volume |
| $3.94 | $3.94 | $3.76 | $511.0K | 134.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $3.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.84 | 11883 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| AVH (ASX) Chart |